CASE STUDY | MEDICAL COMMUNICATIONS
When Scientific Alignment Was Missing, We Unified the Narrative.
THE CHALLENGE
Clinical Evidence Was Established—But Not Consistently Activated in Practice
A global pharmaceutical company sought to improve early identification of patients at risk for renal disease. The Urine Albumin-Creatinine Ratio (UACR) is one of the earliest and most sensitive markers of chronic kidney disease, yet it remained underutilized in routine clinical practice.
As a result, a significant portion of at-risk patients were not identified early enough to initiate guideline-directed therapies that slow disease progression and reduce cardiovascular risk.
The challenge was not a lack of clinical evidence—but inconsistent translation of that evidence into clinical understanding, peer-to-peer communication, and everyday decision-making. To drive change, the organization needed a Medical Communications strategy that could establish clarity, consistency, and urgency across specialties.
THE BREAKTHROUGH
Establishing a Unified Scientific Platform to Translate Evidence into Clinical Action
BGBx identified that the barrier was not awareness alone—it was alignment. UACR was not consistently used as a shared clinical signal across specialties, limiting its impact on early detection and treatment decisions.
Through our proprietary Breakthrough Process, powered by 3D Science, BGBx Medical Communications experts established a unified scientific platform—positioning UACR as a standard risk marker and creating a consistent clinical narrative across all stakeholder interactions.
The approach included:
- Core narrative development to establish aligned communication points across all materials and interactions
- Speaker content development, including slide decks, case-based learning modules, roundtables, leave-behinds, TL videos, and FAQ documents
- Speaker training through train-the-trainer and speaker training programs
- Multichannel medical communications across speaker programs, HCP materials, and educational channels
- Clinical integration tools and resources to support incorporation of UACR testing into routine workflows
This structured approach transformed fragmented education into a cohesive Medical Communications system to ensure scientific consistency, strengthen peer-to-peer engagement, and enable broader adoption of biomarker testing in practice.
THE RESULTS
Stronger Scientific Alignment and Increased Biomarker Adoption in Practice
- Strengthened alignment across Medical Affairs and Field Medical teams
- Increased engagement through peer-to-peer education
- Supported broader adoption of UACR testing in clinical practice
- Enabled earlier patient identification and more consistent use of guideline-directed care
This approach transformed scientific education into a coordinated Medical Communications system that helped drive real-world clinical action.
31,000+
HCPs Engaged
Through integrated medical education and speaker programs
3,077 New Patient Starts
In 2024
5,000+
Speaker Programs Delivered
From launch
Our Perspectives on Advertising
2026 Oncology Market Access Trends
Implications of the IRA’s Maximum Fair Price (MFP) Negotiations
340B Drug Discount Program
Let’s Plan Your Next Medical Communications Breakthrough
At BGBx, we design Medical Communications strategies that transform clinical evidence into aligned, actionable scientific understanding—ensuring education drives real-world impact. Let’s build your next breakthrough together.
